1. |
Barczyński M, Konturek A, Stopa M, et al. Total thyroidectomy for benign thyroid disease:is it really worthwhile?[J]. Ann Surg, 2011, 254(5):724-729.
|
2. |
Efremidou EI, Papageorgiou MS, Liratzopoulos N, et al. The efficacy and safety of total thyroidectomy in the management of benign thyroid disease:a review of 932 cases[J]. Can J Surg, 2009, 52(1):39-44.
|
3. |
王會元, 王曉輝, 李非, 等. 甲狀腺全切除術的適應證及安全性分析[J]. 中國普外基礎與臨床雜志, 2013, 20(4):427-431.
|
4. |
邵堂雷, 楊衛平, 丁家增, 等. 雙側結節性甲狀腺腫手術方式的探討[J]. 中華普通外科雜志, 2008, 23(12):939-942.
|
5. |
徐先發, 唐玲, 李洪躍, 等. 甲狀腺全切除術的安全性及有效性探討[J]. 臨床外科雜志, 2010, 18(5):329-331.
|
6. |
孫團起, 吳毅. 甲狀腺結節手術適應證和術式選擇[J]. 中國普外基礎與臨床雜志, 2011, 18(8):803-805.
|
7. |
鄭澤霖, 孫輝, 蓋寶東. 甲狀腺疾病外科治療的熱點和難點[J]. 中國普外基礎與臨床雜志, 2008, 15(5):307-310.
|
8. |
魏濤, 朱精強. 甲狀腺手術理念進展與新型手術器械在甲狀腺外科中的應用[J]. 中國普外基礎與臨床雜志, 2011, 18(2):220-224.
|
9. |
李明暉, 羅南. 歐洲五維健康量表(EQ-5D)中文版應用介紹[J]. 中國藥物經濟學, 2009, (1):49-57.
|
10. |
衛生部統計信息中心. 2008中國衛生服務調查研究(第四次家庭健康詢問調查分析報告)[R]. 北京:中國協和醫科大學出版社, 2009:17-19.
|
11. |
于曉會, 單忠艷. 甲狀腺結節的病因與流行病學趨勢[J]. 中國普外基礎與臨床雜志, 2011, 18(8):800-802.
|
12. |
Schmitz-Winnenthal FH, Schimmack S, Lawrence B, et al. Quality of life is not influenced by the extent of surgery in patients with benign goiter[J]. Langenbecks Arch Surg, 2011, 396(8):1157-1163.
|
13. |
Shah MD, Witterick IJ, Eski SJ, et al. Quality of life in patients undergoing thyroid surgery[J]. J Otolaryngol, 2006, 35(4):209-215.
|
14. |
Malterling RR, Andersson RE, Falkmer S, et al. Differentiated thyroid cancer in a Swedish county—long-term results and quality of life[J]. Acta Oncol, 2010, 49(4):454-459.
|
15. |
Pelttari H, Sintonen H, Schalin-Jäntti C, et al. Health-related quality of life in long-term follow-up of patients with cured TNM stage Ⅰ or Ⅱ differentiated thyroid carcinoma[J]. Clin Endocrinol (Oxf), 2009, 70(3):493-497.
|
16. |
Mazzaferri EL, Jhiang SM. Long-term impact of initial surgicaland medical therapy on papillary and follicular thyroid cancer[J]. Am J Med, 1994, 97(5):418-428.
|
17. |
Pelizzo MR, Boschin IM, Toniato A, et al. Papillary thyroid carcinoma:35-year outcome and prognostic factors in 1 858patients[J]. Clin Nucl Med, 2007, 32(6):440-444.
|
18. |
Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgeryaffects survival for papillary thyroid cancer[J]. Ann Surg, 2007, 246(3):375-381.
|
19. |
NCCN. NCCN guideline[EB/OL]. 2012-12-20. http://www. nccn. org/professionals/physician_gls/f_guidelines. aspthyroid.
|
20. |
Cooper DS, Doherty GM, Haugen BR, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
|
21. |
Vaiman M, Nagibin A, Olevson J. Complications in primary and completed thyroidectomy[J]. Surg Today, 2010, 40(2):114-118.
|
22. |
Barczyński M, Konturek A, Hubalewska-Dydejczyk A, et al. Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter[J]. World J Surg, 2010, 34(6):1203-1213.
|
23. |
Sosa JA, Bowman HM, Tielsch JM, et al. The importance of surgeon experience for clinical and economic outcomes fromthyroidectomy[J]. Ann Surg, 1998, 228(3):320-330.
|
24. |
Watt T, Bjorner JB, Groenvold M, et al. Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO):an initial examination[J]. Qual Life Res, 2009, 18(4):483-496.
|
25. |
Watt T, Hegedüs L, Groenvold M, et al. Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO[J]. Eur J Endocrinol, 2010, 162(1):161-167.
|